PATENT CLAIM ANALYSIS

Application Number: 15861065
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "053000"]

Abstract:
Provided herein are prostaglandin F 2α  analog compositions and methods for treating migraines.

Claim (Index 13):
The method of  claim 10 , wherein the administration to the subject is oral administration.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15110295', '15021789', '15627238', '15142461', '12260534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593894147042679
- 35 USC 102 Novelty (BERT): 0.5627123884856998
- Combined Prediction Score: 0.7397217120824111
- Mean Citation Score: 270.90973799999995
- Max Citation Score: 441.584
- Similarity Product: 304.0680849666596

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test